Regulatory Information Management

Consumer Drug Take-Back solution for Manufacturers New Product Icon 

Inmar Intelligence

Booth: 106

A growing number of state and local governments have passed legislation mandating drug take-back programs funded by pharma manufacturers due to public health concerns related to opioid misuse, drug diversion, and environmental contamination. To date, these laws have been developed in silos and have small but consequential differences in their requirements, creating a fractured landscape that makes it challenging (and expensive) for manufacturers to ensure compliance in each individual jurisdiction. Inmar’s Consumer Drug Take-Back program mitigates legislative and financial risk by leveraging our existing Rx reverse logistics infrastructure, promotional capabilities, and nationwide pharmacy relationships to implement a low-cost solution with the capacity to scale as needed. Inmar manages compliance in each jurisdiction on your behalf by providing multiple disposal options (kiosks, mail-back envelopes, etc.) as well as fully-compliant transportation and destruction. As required by law, Inmar’s media team implements impactful, low-cost consumer awareness campaigns and provides manufacturers with the required reporting on program efficacy.

Other product: DSCSA Compliance


Video






Request Information





 
By requesting information, you agree to share the email you provided at the time of registration with the exhibitor for follow-up. Click on “Submit” to share your email or “Cancel” to cancel your information request.
 
 
Comments